Ander Burgaña Agoües

Mr. Ander Burgaña Agoües

Primary Care, Fundació Mútua Terrassa, Terrassa, Spain
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
AAAnder Burgaña Agoües
Ander Burgaña Agoües
MGMARTA SERRA GALLEGO
MARTA SERRA GALLEGO
RRRaquel Hernández Resa
Raquel Hernández Resa
BLBeatriz Joven Llorente
Beatriz Joven Llorente
MAMaria Lloret Arabi
Maria Lloret Arabi
TPTomás Pérez Porcuna
Tomás Pérez Porcuna
Background: SARS-CoV-2 has caused a high mortality in institutionalised individuals. There are very few studies on the involvement and the real impact of COVID-19 in nursing homes. This study analysed factors related to morbidity and mortality of COVID-19 in institutionalised elderly people. Methods: This cohort study included 842 individuals from 12 nursing homes in Sant Cugat del Vallès (Spain) from 15 March to 15 May 2020. We evaluated individual factors (demographic, dependence, clinical, and therapeutic) and those related to the nursing homes (size and staff) associated with infection and mortality by SARS-CoV-2. Infection was diagnosed by molecular biology test. Results: Of the 842 residents included in the analysis, 784 underwent a Polymerase Chain Reaction (PCR) test; 74.2% were women, the mean age was 87.1 years, and 11.1% died. The PCR test was positive in 44%. A total of 33.4% of the residents presented symptoms compatible with COVID-19 and of these, 80.9% were PCR-positive for SARS-CoV-2. Infection by SARS-CoV-2 among residents was associated with the rate of staff infected in the homes. Mortality by SARS-CoV-2 was related to male sex and a greater grade of dependence measured with the Barthel index. Conclusions: SARS-Cov-2 infection in institutionalised people is associated with the infection rate in nursing home workers and mortality by SARS-Cov-2 with sex and greater dependency according to the Barthel index. Adequate management of nursing home staff and special attention to measures of infection control, especially of individuals with greater dependence, are keys for successful management of future pandemic situations.

1 December 2019 in International Journal for Parasitology: Drugs and Drug Resistance
Verified
Journal Article
Open access
AAAnder Burgaña Agoües
Ander Burgaña Agoües
RARosa Abellana
Rosa Abellana
SYStanislav Zlatanov Yordanov
Stanislav Zlatanov Yordanov
RKRabee Kazan
Rabee Kazan
AOA. Mauricio Pérez Ortiz
A. Mauricio Pérez Ortiz
TPTomás Pérez Porcuna
Tomás Pérez Porcuna
Dientamoeba fragilis is a trichomonad parasite of the human intestine that is found worldwide. However, the biological cycle and transmission of this parasite have yet to be elucidated. Although its pathogenic capacity has been questioned, there is increasing evidence that clinical manifestations vary greatly. Different therapeutic options with antiparasitic drugs are currently available; however, very few studies have compared the effectiveness of these drugs. In the present longitudinal study, we evaluate 13,983 copro-parasitological studies using light microscopy of stools, during 2013-2015, in Terrassa, Barcelona (Spain). A total of 1150 (8.2%) presented D. fragilis. Of these, 739 episodes were finally analyzed: those that involved a follow-up parasitology test up to 3 months later, corresponding to 586 patients with gastrointestinal symptoms (53% under 15 years of age). Coinfection by Blastocystis hominis was present in 33.6% of the subjects. Our aim was to compare therapeutic responses to different antiparasitic drugs and the factors associated with the persistence of D. fragilis post-treatment. Gender, age, and other intestinal parasitic coinfections were not associated with parasite persistence following treatment. Metronidazole was the therapeutic option in most cases, followed by paromomycin: 65.4% and 17.5% respectively. Paromomycin was found to be more effective at eradicating parasitic infection than metronidazole (81.8% vs. 65.4%; p = 0.007), except in children under six years of age (p = 0.538). Although Dientamoeba fragilis mainly produces mild clinical manifestations, the high burden of infection means we require better understanding of its epidemiological cycle and pathogenicity, as well as adequate therapeutic guidelines in order to adapt medical care and policies to respond to this health problem.

28 March 2025 in Medicine
Verified
Journal Article
Open access
AAAnder Burgaña Agoües
Ander Burgaña Agoües
RARosa Abellana
Rosa Abellana
MBMónica Ballestero-Téllez
Mónica Ballestero-Téllez
MRMireia Msc Rajadell-Guiu
Mireia Msc Rajadell-Guiu
MGMarc Garreta
Marc Garreta
TPTomás Pérez Porcuna
Tomás Pérez Porcuna
Dientamoeba fragilis is a globally widespread intestinal parasite and one of the most frequent in humans, often leading to primary care consultations. The pathogenic potential of this parasite remains unclear due to limited evidence and contradictory study results. This study investigated the pathogenicity of D fragilis, focusing on the critical knowledge gap regarding the relationship between parasite load and associated symptomatology. A prospective case-control study matched by household unit was conducted, considering individuals with gastrointestinal symptoms and D fragilis in stool as cases, and their asymptomatic household members with D fragilis in stools as controls. D fragilis detection was performed in parallel using light microscopy and real time-polymerase chain reaction. The study was carried out in 7 primary care centers over 12 months. Parasite load was measured as the number of trophozoites per field at a magnification of 40x by microscopy and by cycle threshold values in RT-PCR. A total of 218 individuals were recruited: 74 symptomatic cases and 144 household members, of whom 57 (39.6%) were D fragilis-positive asymptomatic controls. The proportion of individuals with D fragilis and a parasite load less than 1 trophozoite per field was higher in asymptomatic individuals (controls) than in symptomatic cases (47.7% vs 3.1%, respectively) (P < .001). Parasite load is associated with the presence of gastrointestinal symptoms, supporting the pathogenicity of D fragilis. Any diagnostic approach for D fragilis should incorporate or be complemented by quantitative information to accurately estimate parasite load and enhance treatment decision-making.